Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$3.01 - $5.22 $59,215 - $102,693
-19,673 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$4.83 - $7.35 $444 - $676
92 Added 0.47%
19,673 $97,000
Q4 2021

Feb 04, 2022

BUY
$6.16 - $12.07 $11,808 - $23,138
1,917 Added 10.85%
19,581 $136,000
Q3 2021

Nov 12, 2021

BUY
$9.7 - $14.34 $2,570 - $3,800
265 Added 1.52%
17,664 $177,000
Q2 2021

Aug 02, 2021

SELL
$13.43 - $19.16 $3,572 - $5,096
-266 Reduced 1.51%
17,399 $247,000
Q1 2021

May 06, 2021

BUY
$15.82 - $22.11 $1,297 - $1,813
82 Added 0.47%
17,665 $290,000
Q4 2020

Jan 28, 2021

BUY
$7.91 - $22.95 $139,081 - $403,529
17,583 New
17,583 $364,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.